Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

A man with HIV developed skin and hair issues after starting HIV treatment, which improved with topical treatment.

A newborn with congenital syphilis had unusual hair loss possibly caused by the infection.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Both mouse and rat models are effective for testing alopecia areata treatments.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

People undergoing chemotherapy need better support and information to cope with hair loss.

Antigens from skin cells may cause hair loss in perinevoid alopecia.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Liquid nitrogen cryotherapy worked well for many patients with stubborn alopecia areata.

A boy's hair, nails, and skin improved after 6 months of steroid treatment.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.